Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48,821,304
-
Total 13F shares
-
28,177,146
-
Share change
-
-4,035,274
-
Total reported value
-
$41,701,476
-
Put/Call ratio
-
117%
-
Price per share
-
$1.48
-
Number of holders
-
71
-
Value change
-
-$7,785,512
-
Number of buys
-
36
-
Number of sells
-
23
Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q4 2024
As of 31 Dec 2024,
Werewolf Therapeutics, Inc. - Common Stock (HOWL) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,177,146 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, PFM Health Sciences, LP, MPM BIOIMPACT LLC, BANK OF AMERICA CORP /DE/, BlackRock, Inc., VANGUARD GROUP INC, Rubric Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
71
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.